Barclays Forecasts Strong Price Appreciation for Phibro Animal Health (NASDAQ:PAHC) Stock

Phibro Animal Health (NASDAQ:PAHC) had its target price increased by Barclays from $13.00 to $20.00 in a research report released on Tuesday morning,Benzinga reports. The brokerage currently has an underweight rating on the stock.

Several other equities analysts have also recently issued reports on the stock. JPMorgan Chase & Co. began coverage on shares of Phibro Animal Health in a research report on Tuesday, September 10th. They set a “neutral” rating and a $22.00 price target on the stock. Bank of America upped their target price on Phibro Animal Health from $13.00 to $15.00 and gave the stock an “underperform” rating in a report on Friday, August 30th. Three analysts have rated the stock with a sell rating, one has issued a hold rating and one has given a strong buy rating to the company’s stock. Based on data from MarketBeat.com, the stock presently has an average rating of “Hold” and an average price target of $16.50.

Phibro Animal Health Stock Down 1.9 %

Shares of NASDAQ:PAHC opened at $25.06 on Tuesday. The stock’s 50-day moving average is $22.46 and its 200 day moving average is $19.52. The company has a market cap of $1.01 billion, a PE ratio of 58.28, a P/E/G ratio of 0.65 and a beta of 0.51. The company has a debt-to-equity ratio of 1.81, a current ratio of 3.23 and a quick ratio of 1.69. Phibro Animal Health has a 1 year low of $9.40 and a 1 year high of $25.98.

Phibro Animal Health (NASDAQ:PAHC) last announced its quarterly earnings results on Wednesday, August 28th. The company reported $0.41 EPS for the quarter, topping analysts’ consensus estimates of $0.34 by $0.07. The company had revenue of $273.16 million during the quarter, compared to analyst estimates of $262.44 million. Phibro Animal Health had a return on equity of 21.59% and a net margin of 1.67%. Sell-side analysts anticipate that Phibro Animal Health will post 1.63 EPS for the current year.

Phibro Animal Health Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Wednesday, December 18th. Investors of record on Wednesday, November 27th will be paid a dividend of $0.12 per share. This represents a $0.48 annualized dividend and a yield of 1.92%. The ex-dividend date of this dividend is Wednesday, November 27th. Phibro Animal Health’s payout ratio is currently 111.63%.

Insiders Place Their Bets

In related news, Director E Thomas Corcoran purchased 5,000 shares of the company’s stock in a transaction dated Wednesday, September 4th. The shares were purchased at an average cost of $20.02 per share, with a total value of $100,100.00. Following the transaction, the director now directly owns 25,000 shares in the company, valued at $500,500. This trade represents a 0.00 % increase in their position. The purchase was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Corporate insiders own 50.07% of the company’s stock.

Hedge Funds Weigh In On Phibro Animal Health

Several large investors have recently modified their holdings of the stock. Algert Global LLC increased its stake in Phibro Animal Health by 521.1% during the 3rd quarter. Algert Global LLC now owns 71,335 shares of the company’s stock valued at $1,606,000 after purchasing an additional 59,850 shares in the last quarter. Segall Bryant & Hamill LLC grew its holdings in shares of Phibro Animal Health by 1.7% during the third quarter. Segall Bryant & Hamill LLC now owns 174,569 shares of the company’s stock valued at $3,931,000 after buying an additional 2,971 shares during the last quarter. Thrivent Financial for Lutherans increased its position in shares of Phibro Animal Health by 23.1% during the third quarter. Thrivent Financial for Lutherans now owns 20,791 shares of the company’s stock valued at $468,000 after acquiring an additional 3,907 shares in the last quarter. Pinnacle Associates Ltd. raised its holdings in Phibro Animal Health by 18.8% in the 3rd quarter. Pinnacle Associates Ltd. now owns 24,120 shares of the company’s stock worth $543,000 after acquiring an additional 3,820 shares during the last quarter. Finally, China Universal Asset Management Co. Ltd. boosted its stake in Phibro Animal Health by 63.7% during the 3rd quarter. China Universal Asset Management Co. Ltd. now owns 3,912 shares of the company’s stock valued at $88,000 after purchasing an additional 1,522 shares during the last quarter. Hedge funds and other institutional investors own 99.34% of the company’s stock.

About Phibro Animal Health

Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Israel, Brazil, Ireland, and internationally. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets various products for food and companion animals including poultry, swine, beef and dairy cattle, aquaculture, and dogs.